Literature DB >> 3106337

Identification and characterization of UDP-GalNAc: NeuAc alpha 2-3Gal beta 1-4Glc(NAc) beta 1-4(GalNAc to Gal)N-acetylgalactosaminyltransferase in human blood plasma.

A Takeya, O Hosomi, T Kogure.   

Abstract

Normal human plasma was found to contain beta 1-4N-acetylgalactosaminyltransferase catalyzing the transfer of N-acetylgalactosamine from UDP-GalNAc to 3'-sialyl-lactose, NeuAc alpha 2-3Gal beta 1-4Glc. The transferred N-acetylgalactosaminyl residue was cleaved from the desialylated reaction product by the beta-N-acetylhexosaminidase from jack beans. Methylation and hydrolysis of the desialylated reaction product yielded only 2,3,6-tri-O-methylgalactose and 2,3,6-tri-O-methylglucose as neutral sugars, indicating that the N-acetylgalactosaminyl residue was introduced at position C-4 of the galactosyl residue of 3'-sialyllactose. The enzyme required Mn2+ ions for its activity and showed a pH optimum between 6.5 and 8.5. By using a wide variety of oligosaccharides and glycoconjugates, the acceptor specificity of the beta 1-4N-acetylgalactosaminyltransferase was investigated. No detectable amount of N-acetylgalactosamine was transferred to either 6'-sialyllactose or lactose. The enzyme did not act on ganglioside GM3, NeuAc alpha 2-3Gal beta 1-4Glc-ceramide, suggesting that the hydrophobic ceramide portion of GM3 interferes with the enzyme reaction. On the other hand, glycoproteins carrying terminal NeuAc alpha 2-3Gal beta 1-4GlcNAc structures on their N-linked oligosaccharide chains, e.g. Tamm-Horsfall glycoprotein, were efficient acceptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106337     DOI: 10.1093/oxfordjournals.jbchem.a121898

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Molecular cloning, gene organization and expression of the human UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase responsible for the biosynthesis of the blood group Sda/Cad antigen: evidence for an unusual extended cytoplasmic domain.

Authors:  Maria-Dolores Montiel; Marie-Ange Krzewinski-Recchi; Philippe Delannoy; Anne Harduin-Lepers
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

2.  A soluble form of Sda-beta 1,4-N-acetylgalactosaminyltransferase is released by differentiated human colon carcinoma CaCo-2 cells.

Authors:  F Serafini-Cessi; N Malagolini; S Guerrini; I Turrini
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

3.  Identification of transient glycosylation alterations of sialylated mucin oligosaccharides during infection by the rat intestinal parasite Nippostrongylus brasiliensis.

Authors:  N G Karlsson; F J Olson; P A Jovall; Y Andersch; L Enerbäck; G C Hansson
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

4.  Identification and characterization of the Sda beta 1,4,N-acetylgalactosaminyltransferase from pig large intestine.

Authors:  N Malagolini; F Dall'Olio; S Guerrini; F Serafini-Cessi
Journal:  Glycoconj J       Date:  1994-04       Impact factor: 2.916

5.  beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma cell line AH7974F.

Authors:  J K Hidari; S Ichikawa; K Furukawa; M Yamasaki; Y Hirabayashi
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

6.  Substrate specificity and distribution of UDP-GalNAc:sialylparagloboside N-acetylgalactosaminyltransferase in the human stomach.

Authors:  T Dohi; A Nishikawa; I Ishizuka; M Totani; K Yamaguchi; K Nakagawa; O Saitoh; S Ohshiba; M Oshima
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Purification and characterization of a soluble recombinant human ST6Gal I functionally expressed in Escherichia coli.

Authors:  Kazuya I P J Hidari; Nobuhiro Horie; Takeomi Murata; Daisei Miyamoto; Takashi Suzuki; Taiichi Usui; Yasuo Suzuki
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 3.009

8.  Glycoproteomic and Phenotypic Elucidation of B4GALNT2 Expression Variants in the SID Histo-Blood Group System.

Authors:  Linn Stenfelt; Jonas Nilsson; Åsa Hellberg; Yew Wah Liew; Jenny Morrison; Göran Larson; Martin L Olsson
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

Review 9.  B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen.

Authors:  Guerard Byrne; Saadullah Ahmad-Villiers; Zeji Du; Christopher McGregor
Journal:  Xenotransplantation       Date:  2018-03-31       Impact factor: 3.907

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.